Parkinson Disease Panel

New York
Approved

Genes

AFG3L2, ATP13A2, ATP6AP2, C19orf12, CHCHD2, COASY, CP, CYP27A1, DCTN1, DNAJC5, DNAJC6, FBXO7, FTL, GBA, GCH1, LRRK2, MAPT, NPC1, NPC2, NUS1, PANK2, PARK7, PDGFB, PDGFRB, PINK1, PLA2G6, POLG, PRKN, PRKRA, PTS, RAB39B, SLC20A2, SLC30A10, SLC6A3, SMPD1, SNCA, SYNJ1, TH, TWNK, VPS13A, VPS35, WDR45, XPR1, ZFYVE26

Conditions

  • Dopa-responsive parkinsonism
  • Atypical parkinsonism
  • Progressive Supranuclear Palsy (PSP)
  • Parkinson Disease
  • Parkinsonism
  • Movement Disorder
  • Tremors
  • Bradykinesia

Clinical Utility

  • Molecular confirmation of a clinical diagnosis
  • Identification of at-risk family members
  • Assist with treatment/ management decisions
  • Recurrence risk assessment

Lab Method

  • Next-Gen Sequencing
  • Deletion/Duplication Analysis
  • Capillary Sequencing

Test Code

T401

CPT Codes*

81404x1, 81405x2, 81406x5, 81408x1, 81479x3

ABN Required

No

Turnaround Time**

4 weeks

Preferred Specimen

2-5 mL Blood - Lavender Top Tube

Alternative Specimen

Buccal Swabs

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.

Need something else?

Search More Tests